Leerink: Translate Bio's Cystic Fibrosis Candidate Could Generate

Frontiers Emerging Therapeutic Approaches for Cystic Fibrosis. From Gene Editing to Personalized Medicine

Low-Dose Vertical Inhibition of the RAF-MEK-ERK Cascade Causes Apoptotic Death of KRAS Mutant Cancers - ScienceDirect

cala-10k_20181231.htm

grph-10k_20211231.htm

With $3.2B, Sanofi takes in mRNA partner Translate Bio in buyout deal

SEC Filing ProQR Therapeutics

Coronavirus tracker: Sanofi, Takeda, Lilly execs call for ongoing vax funding; Leerink analyst questions timelines

EX-99.1

SEC Filing Arcturus Therapeutics, Inc.

Beyond Air Inc - 10K - Annual Report - June 22, 2023

Antisense oligonucleotide-based drug development for Cystic Fibrosis patients carrying the 3849+10kb C-to-T splicing mutation

SEC Filing ProQR Therapeutics